Abstract: The mouse has become an important model for immunological studies including innate immunity. Creating transgenic mice offers unique possibilities to study gene-function relationships. However, relatively little is known about the physiology of neutrophils from wild-type mice. Do they behave like human neutrophils, or are there species-specific differences that need to be considered when extrapolating results from mice to humans? How do we isolate neutrophils from mice? For practical reasons, many studies on mouse neutrophils are done with bone marrow cells. However, human bone marrow neutrophils appear to be heterogeneous and functionally immature. We have isolated and compared neutrophils from mouse bone marrow and from peripheral blood obtained by tail bleeding. Using the same Percoll density gradient for both preparations, we have obtained morphologically mature neutrophils from bone marrow and blood. Both cell populations responded to formylmethionyl-leucyl-phenylalanine (fMLF) with primary and secondary granule release and superoxide production. Quantitative analysis of our data revealed minor differences between cells from bone marrow and blood. Superoxide production and primary granule release were stimulated at lower fMLF concentrations in blood neutrophils. However, the amplitude and the kinetics of maximal responses were similar. The principal difference was the lifespan of the two cell populations. Bone marrow cells survived significantly longer in culture, which may suggest that they are receiving antiapoptic signals that are absent in the blood. Our data suggest that mice have a large reservoir of functionally competent neutrophils in their bone marrow. This reservoir may be needed to replace circulating neutrophils rapidly during infection. J. Leukoc. Biol. 75: 000 -000; 2004.
INTRODUCTION
Polymorphonuclear neutrophils (PMN) are the first line of defense against bacterial infections (reviewed in ref. [1] ). They are designed to phagocytose bacteria and kill them by releasing the contents of their cytoplasmic granules into the phagosome and by producing reactive oxygen intermediates (ROIs). These bactericidal functions are essential for the host defense. However, several chronic inflammatory diseases such as cystic fibrosis or inflammatory bowel disease are associated with a massive influx of PMN. Overactivation of these cells contributes to destruction of host tissue. The search for new treatment opportunities in chronic inflammation requires a better understanding of control mechanisms in neutrophil granule release and oxygen radical production. Neutrophils belong to the myeloid lineage, which multiplies and differentiates in the bone marrow. Mature neutrophils are stored in the bone marrow for several days and then released into the blood, where they remain for only a few hours [2] before dying or migrating into tissues. Normal PMN turnover in humans is mediated by apoptosis, a process that presumably down-regulates proinflammatory and microbicidal functions and prepares these cells for removal from the tissue by macrophages [3] . Morphologically mature neutrophils have also been identified in the bone marrow of humans and mice, but they were found to be functionally immature [4] . The signals that retain immature neutrophils in the bone marrow and regulate the level of mature neutrophils in the blood are poorly understood. We wanted to determine whether neutrophils become functionally mature before or after entering the bloodstream.
Understanding cellular functions on the molecular level has been greatly enhanced by the possibility to mutate, suppress, or overexpress individual genes. However, primary human neutrophils are too short-lived for those techniques, and the cell-culture models for neutrophils do not fully differentiate and are difficult to transfect. This has prompted a renewed interest into mouse neutrophils, which could be obtained from genetically modified animals. The number of neutrophils that can be obtained from mouse blood is very limited [5] . Therefore, many researches use bone marrow preparations to study neutrophils in mice. How are the functional characteristics of these cells compared with blood neutrophils? Is it possible to obtain functionally mature neutrophils from mouse bone marrow?
We wanted to improve our knowledge about the physiology of mouse neutrophils and to compare the functional capacities of bone marrow and blood neutrophils. Here, we present evidence that a subpopulation of mouse bone marrow leukocytes consists of functionally mature neutrophils.
MATERIALS AND METHODS

Preparation of mouse neutrophils from peripheral blood
Mouse blood (350Ϯ50 l per animal) was collected by tail bleeding from C57BL6 mice (Depre, Saint Doulchard, France) into Hanks' balanced saline solution (HBSS)-EDTA [HBSS without calcium, magnesium, phenol red, and sodium bicarbonate; pH 7.2, 15 mM EDTA, bovine serum albumin (BSA), 1%; ref . 5] . After centrifugation (400 g, 10 min, 4°C), cells were resuspended in 1 ml HBSS-EDTA. The cells were overlaid with a three-layer Percoll gradient of 78%, 69%, and 52% Percoll (Amersham Pharmacia Biotech, Uppsala, Sweden), respectively, diluted in HBSS (100% Percollϭnine parts Percoll and one part 10ϫ HBSS), and centrifuged (1500 g, 30 min, room temperature) without braking. The refractive index (RI) of each Percoll layer was determined, and the density (␦) of the layer was calculated according to the manufacturer's information (52%, RI 1.347, ␦ϭ1.083 g/ml; 69%, RI 1.349, ␦ϭ1.090 g/ml; 78%, RI 1.350, ␦ϭ1.110 g/ml). The neutrophils from the 69%/78% interface and the upper part of the 78% layer were harvested into BSA 1%-coated tubes, after carefully removing the cells from the upper phases. After one wash with 2 ml HBSS-EDTA ϩ BSA 1%, remaining red cells were eliminated by hypotonic lysis. After a final wash with 2 ml HEPES buffer (140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, pH 7.2), 350,000 Ϯ 40,000 cells were obtained per mouse, 97 Ϯ 1% neutrophils, identified by staining the nuclei with Tü rks reagent (Merck, Darmstadt, Germany). These cells were suspended in HEPES buffer ϩ 9 mM glucose at 10 6 cells/ml and used within 6 h. On several occasions, isolated cells were analyzed by cytospin centrifugation followed by Wright-Giemsa coloration according to the manufacturer's instructions (Hemacolor, Merck). Chemicals were bought from Sigma Chemical Co. (St. Louis, MO) unless indicated otherwise.
Preparation of mouse neutrophils from bone marrow
Mice were killed, the femur and the tibia from both hind legs were removed and freed of soft tissue attachments, and the extreme distal tip of each extremity was cut off [6] . HBSS-EDTA solution was forced through the bone with a syringe. After dispersing cell clumps, the cell suspension was centrifuged (400 g, 10 min, 4°C) and resuspended in 1 ml HBSS-EDTA. Cells were then treated on a three-layer Percoll gradient exactly as described above for blood cells. We obtained 6 Ϯ 0.6 ϫ 10 6 cells per mouse, and 94 Ϯ 1% of them were morphologically mature neutrophils (bands and segmented).
Preparation of human neutrophils
Human PMN were isolated from blood by 20% dextran (1:1) sedimentation at room temperature for 40 min. The leukocyte-rich upper fraction was collected, layered on a continuous Histopaque -1077 gradient, and centrifuged (1000 g, 20 min, room temperature) without braking. The remaining red cells in the neutrophil pellet were eliminated by hypotonic lysis and spun down (300 g, 10 min, 4°C). After a final wash with 2 ml phosphate-buffered saline (PBS), staining the nuclei with Tü rks reagent identified the neutrophils. Cells (1.5ϫ10 8 ) were suspended in 200 l PBS supplemented with 2% protease inhibitor cocktail. The isolated neutrophils were kept on ice until the experiments were performed within a few hours after the preparation.
Superoxide production
ROIs were quantified by measuring luminol-dependent chemiluminescence at 37°C using a Wallac 1420 multilabel counter (Perkin Elmer, Courtaboeuf, France) at approximately one measurement per well every 6 s. White polypropylene, 96-well plates (Nunc, Roskilde, Denmark) were covered with BSA (1%, 1 h, 37°C). After coating, the plates were washed three times with HEPES buffer. Mouse neutrophils (2ϫ10 4 cells) were suspended with 10 g/ml luminol, 5 g/ml cytochalasin B, 4 U/ml horserardish peroxidase, and HEPES buffer for a final volume of 200 l per well. The cells were stimulated with formylmethionyl-leucyl-phenylalanine (fMLF), and superoxide anion generation was measured by integrating photon counts for 5 min before and after agonist addition. The solvent control, dimethyl sulfoxide (DMSO), did not stimulate ROI production.
␤-Glucuronidase release
To measure the release of the primary granules, we established a method of detecting the activity of the marker ␤-glucuronidase from the supernatants of stimulated mouse neutrophils. Tubes were coated with BSA (1%, 1 h, 37°C). Mouse neutrophils (2ϫ10 4 cells) were suspended in these tubes in HEPES buffer ϩ glucose for a final volume of 100 l with 5 g/ml cytochalasin B (unless otherwise indicated). Cells were prewarmed for 10 min at 37°C before addition of various concentrations of fMLF, 1 M A23187, 200 nM phorbol 12-myristate 13-acetate (PMA), or solvent (DMSO) alone. After incubation at 37°C for 30 min, secretion was stopped by rapid cooling on ice and addition of 100 l ice-cold HEPES buffer ϩ glucose and was centrifuged (400 g, 10 min, 4°C). Duplicates of 50 l supernatant were dispensed in 96-microwell plates, and 50 l reaction medium [0.1 M sodium acetate, pH 4.0, 0.02% Triton X-100, 5 mM 4-methylumbelliferyl ␤-D-glucuronide (Roth, Karlsruhe, German)] was added. The reaction was stopped after 2 h at 37°C by adding 50 l 0.3 M glycine/NaOH, pH 10.4, 10 mM EGTA. Fluorescence was quantified by using a Wallac 1420 multilabel counter with 365 nm excitation and 450 nm emission wavelength. ␤-Glucuronidase release from murine PMN is expressed as percent of release compared with the total content detected in supernatants of Triton X-100-lysed PMN. Background release in the presence of solvent was subtracted.
Lactoferrin release
Mouse neutrophils (2ϫ10 4 cells) were suspended in 100 l HEPES buffer ϩ glucose with 5 g/ml cytochalasin B and were prewarmed for 10 min at 37°C before addition of various concentrations of fMLF, 1 M A23187, 200 nM PMA, or solvent (DMSO) alone. After incubation at 37°C for 30 min, secretion was stopped by rapid cooling on ice and addition of 100 l ice-cold buffer and was centrifuged (400 g, 10 min, 4°C). Supernatants or a solution of human lactoferrin (10 -50 ng per well) were diluted twofold in carbonate buffer (90 mM NaHCO 3 , 36 mM Na 2 CO 3 , pH 9.6) and were added to Nunc Maxisorp F96 immunoplate wells for 3 h at 37°C. Nonspecific binding sites were blocked with PBS-Tween 1%, supplemented with 2% BSA overnight at 4°C. PBSTween 1% was used for all subsequent steps, which were conducted at room temperature and separated by several washings. Rabbit anti-human lactoferrin antibody (dilution 1/1000) was added for 1 h, followed by goat peroxidaseconjugated anti-rabbit immunoglobulin G (IgG; dilution 1/10,000) for 1 h. 3.3.5.5Ј-Tetramethylethylenediamine (5 mg/ml; Interchim, Montlucon, France) in 100 mM acetate buffer, pH 6.0, 1.2% H 2 O 2 , was added for 15 min, followed by 750 mM H 2 SO 4 . Absorbance was read at 450 nm with a Wallac 1420 microplate reader, and the lactoferrin concentration was calculated using the human lactoferrin calibration curve. As data obtained with mouse samples could not be quantified exactly using standard curves done with human lactoferrin, lactoferrin release from murine PMN is expressed as fold increase compared with the amount detected in supernatants of unstimulated PMN [6] .
Western blotting
The specificity of the anti-human lactoferrin antibody with murine lactoferrin was determined by Western blotting. Human and murine PMN suspensions were divided into two batches. One part was incubated in HEPES buffer with 200 nM PMA at 37°C for 30 min in the presence of 5 g/ml cytochalasin B. The other part was taken up in lysis buffer (20 mM Tris, 400 mM KCl, 20% glycérol, 2 mM dithiothreitol) for 20 min on ice and lysed by three cycles of freezing in liquid nitrogen/thawing on ice. Both batches were then spun down, and the supernatant was solubilized in 4ϫ concentrated sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and boiled for 10 min. Samples were run on a 10% SDS-PAGE, electroblotted onto nitrocellulose sheets (Hybond N, Amersham Pharmacia Biotech), blocked with 3% BSA, and probed with rabbit anti-human lactoferrin antibody (dilution 1/500) followed by goat peroxidase-conjugated, anti-rabbit IgG (dilution 1/10,000) in PBS-Tween 1%, BSA 3%. Signal was developed and analyzed using a chemiluminescence substrate (Roche Diagnostics France S.A, Meylan), autoradiographic film (Hyperfilm ECL, Amersham Pharmacia Biotech), and the GelDoc2000 imaging system (BioRad, Hercules, CA).
Viability of neutrophils in culture
Neutrophils from mouse blood and bone marrow were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum and 100 U/ml penicillin and streptomycin on 96-well plates (20,000 cells/50 l/well) for up to 48 h at 5% CO 2 , 37°C. The bioluminescence of adenosine 5Ј-triphosphate (ATP) was used as a marker of cell viability using the Cell Titer Glo TM luminescent cell viability assay (Promega, Madison, WI) according to the manufacturer's instructions. The luminescence was read on the Wallac 1420 plate reader and reported to a standard curve for the determination of the number of viable cells.
Analysis and statistics
Data are expressed as mean Ϯ SEM. Statistical significance was tested with unpaired Student's t-test; P values below 0.05 were considered significant. Sigmoidal and exponential fits were performed in Origin (Microcal, Northampton, MA). The half-life of the cells was determined as t 1/2 ϭ 0.693 ϫ , with being the time constant of the exponential decay fit.
RESULTS
Isolation of morphologically mature neutrophils from mouse bone marrow
Leukocytes change their buoyant density during differentiation. Mature neutrophils have a higher density than their precursors and can thus be isolated by density gradient centrifugation [7] . Using a discontinuous, three-layer Percoll density gradient, we were able to isolate morphologically mature cells from mouse blood and bone marrow (Fig. 1, A and B) . Cells from both preparations have a donut-shaped, segmented nucleus, typical for mouse neutrophils. The cells from bone marrow and blood have similar diameter in cytospin preparations (10.12Ϯ0.11 m and 10.57Ϯ0.21 m, nϭ71 and 53, respectively). The nuclei of bone marrow PMN appeared less condensed, which might indicate that they were slightly less mature than the cells isolated from blood. Biermann et al. [9] reported that some mouse leukocytes with ring-like nuclei are monocytic instead of granulocytic. Based on their morphologic criteria, a small minority of the cells in our preparation might belong to this category. Isolation of neutrophils from the bone marrow allowed us to extract 17-fold the number of neutrophils per mouse when compared with the isolation of neutrophils from peripheral blood (Fig. 1C) . The percentage of recovery was calculated according to the values given by Chervenick et al. [8] , knowing that leukocyte counts are reported to be variable in mice and to be influenced by a variety of factors [10] . Chervenick et al. [8] reported that the marrow hematopoietic tissue in a mouse contained 12 ϫ 10 6 nucleated cells per gram of body weight, of which 18.7% was in tibias and femurs. Neutrophils and neutrophil precursors constituted ϳ40% of marrow cells as determined by Wright's stain and peroxidase staining. Fortythree percent of these marrow neutrophils were bands and segmented cells that are considered to constitute the effective storage compartment of marrow, as they seem to be the only cells that are released to the blood in large numbers under ordinary circumstances [8] . According to these values, we recovered over 60% of the morphologically mature neutrophils from the bone marrow. The recovery from blood was over 85%, suggesting that mouse blood PMN have a fairly homogenous density.
Only few studies have compared the functional characteristics of bone marrow and blood neutrophils, and to our knowledge, none of these studies was done on mice. We concentrated on the bactericidal functions that can be induced by the bacterial peptide fMLF, which has been widely used to characterize human neutrophils. These functions are the generation of ROIs by the reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase as well as the release of secondary and primary granules [1] .
fMLF-induced superoxide production from blood and bone marrow mouse neutrophils We established a method, which determined the amount of ROIs by luminol-dependent chemiluminescence and which allows a quantification of the production of free radicals on few cells (20,000 cells per well). To investigate the patterns of the respiratory burst in blood and bone marrow neutrophils, cytochalasin B-pretreated cells were stimulated with 3 M fMLF, and the superoxide production was recorded 5 min before and 5 min after the stimulation (Fig. 2A) . As expected from human neutrophils, fMLF induced a rapid and transient production of ROIs. Compared with peripheral blood neutrophils, the bone marrow cells showed no defect in superoxide release upon stimulation with fMLF. The activity of the NADPH oxidase in neutrophils in response to a stimulation by fMLF is known to be increased by preincubation of the cells with the actin-binding and microfilament-disrupting compound, cytochalasin B. In fact, we found virtually no ROI production from bone marrow neutrophils in the absence of cytochalasin B (Fig. 2B) 
For a quantitative comparison of the ROI production from blood and bone marrow PMN, we integrated luminescence signal over 5 min to evaluate the total superoxide release. The response to a wide range of concentrations of fMLF in the presence of cytochalasin B (Fig. 2C) 
Mouse neutrophils release ␤-glucuronidase, a marker for primary granules
The enzymatic contents of the granules human PMN are wellknown [11] , and those of the murine neutrophils are much less known. Based on the assumption that ␤-glucuronidase, which is known to be present in mouse neutrophils [12] , is localized to the same granules as in their human counterparts, we developed a method for primary granule secretion by measuring the ␤-glucuronidase activity using a fluorescent substrate for this enzyme. The assay measures the activity of this enzyme in the supernatant of just 5000 cells. The enzyme release was compared with the total ␤-glucuronidase activity from Tritonlysed PMN. Blood and bone marrow PMN had the same total ␤-glucuronidase activity (107.6Ϯ3.6 vs. 106.4Ϯ4.5 arbitrary fluorescence units; nϭ33 and 18). Addition of fMLF stimulated the release of up to 25% of the primary granules in mouse neutrophils. Similar to the ROI production, the dose-response curve to fMLF for primary granule release was sigmoid with a maximal response at 3 M and 10 M fMLF for blood and bone marrow PMN, respectively (Fig. 3A) . The values of EC 50 were similar to those obtained for ROI production (0.71Ϯ0.11 M and 1.19Ϯ0.09 M, PϽ0.01). The maximal response had a tendency to be higher for bone marrow PMN, but this difference was not statistically significant (Pϭ0.28).
Like the production of superoxide anions, primary granule release in human neutrophils is enhanced in the presence of cytochalasin B [13] . The same was true for mouse neutrophils, whether from blood or from bone marrow (Fig. 3B) . Primary granule release in the absence of cytochalasin B was barely detectable and significantly enhanced about fivefold in its presence (PϽ0.05). Stimulus-secretion coupling involves several signaling steps that can be activated by specific agonists. Figure 3B shows that the protein kinase C (PKC) activator PMA (200 nM) and the Ca 2ϩ ionophore A23187 (1 M) were also effective agonists of primary granule secretion in blood and bone marrow PMN, although less efficient than fMLF. Thus, PKC and Ca 2ϩ appeared to be involved in mouse neutrophil exocytosis.
Taken together, blood and bone marrow mouse PMN can be stimulated to mobilize ␤-glucuronidase-containing primary granules in response to the chemoattractant fMLF, to PMA, and to the Ca 2ϩ ionophore A23187 in the presence of cytochalasin B. The affinity for fMLF was similar as for ROI production and about twofold higher for blood PMN compared with bone marrow PMN. The overall response was similar between the two cell populations.
Lactoferrin release by mouse neutrophils
A characteristic feature of neutrophils is the presence of several types of granules with specific physiological roles and partially distinct mechanisms of exocytosis. After having evaluated the secretion of the primary granules, we wanted to know if on the one hand, the secondary granules were liberated in response to the same agonists and on the other hand, how much fMLF was necessary to stimulate the release of these granules. We chose lactoferrin as a marker for secondary granules that can be detected by enzyme-linked immunosorbent assay (ELISA) [6] . There was no antibody against mouse lactoferrin available; therefore, we tested the specificity of a commercial antibody against human lactoferrin by Western blot. Human lactoferrin purified from human milk (90 kDa, according to the manufacturer), BSA, the supernatant of PMA-stimulated human and murine neutrophils, or lysed human and murine neutrophils were analyzed by SDS-PAGE and Western blot. PMA is known to stimulate secondary granule release from human neutrophils [14] . Figure 4 shows that the anti-human lactoferrin antibody recognized one single band in each sample, at 91 kDa or 87 kDa in the supernatant and the lysate of human and mouse neutrophils, respectively. The molecular weight of this band and the fact that it appeared in the supernatant of PMA-stimulated PMN confirmed this protein to be lactoferrin. However, we could note a slight difference in migration between human and mouse lactoferrin, despite a similar number of amino acids (711 for human, accession number NP_002334; 707 for mouse, accession number BAA13633; protein sequence homology: 70%) and a similar theoretical, molecular mass (78.3 kDa for human; 77.7 kDa for mouse). This difference in migration might be explained by a difference in the number of sites and extent of glycosylation of this protein. Indeed, the polypeptide chain of human lactoferrin possesses two glycosylation sites with five different glycopeptide structures possible [15] , and the mouse lactoferrin presents only one site of glycosylation [16] .
Based on the specificity of the commercial anti-human lactoferrin antibody described above, we set up an ELISA for the detection of mouse lactoferrin released from mouse neutrophils. The technique was essentially as described before by Mocsai and colleagues [6] with two notable differences. We used cells in suspension instead of adherent cells, and we used just 20,000 cells per assay. As previously reported with azurophilic granule exocytosis, nonadherent mouse neutrophils could be stimulated to mobilize lactoferrin-containing, specific granules in response to fMLF, PMA, and A23187 (Fig. 5) . The dose-response curve was sigmoid over the same range as for ROI production and primary granule release. The maximal lactoferrin release was the same from bone marrow PMN and from blood PMN. The EC 50 for blood cells, 0.80 M, was similar to the EC 50 for ROI production and primary granule exocytosis. The EC 50 for bone marrow PMN, 0.20 M, instead, was lower than the values for the other responses. Thus, in contrast to ROI production and primary granule exocytosis, lactoferrin release in response to fMLF occurred at a slightly higher affinity in bone marrow PMN compared with blood PMN.
To assess the role of the actin cytoskeleton in lactoferrin release, we preincubated cells in the presence or in the absence of cytochalasin B and then stimulated with 3 M fMLF (Fig. 5B) . Secondary granule exocytosis was enhanced in bone marrow and blood PMN; in fact, there was no significant lactoferrin release in the absence of cytochalasin B. We also stimulated lactoferrin release by PMA (200 nM) and the Ca 2ϩ ionophore A23187 (1 M). Both were effective stimulators of specific granule release with a similar potency as fMLF. It is interesting to note that the response of bone marrow PMN to these two agonists was significantly more important than the response of blood PMN (PϽ0.05).
Blood neutrophils have a reduced viability
Blood neutrophils are short-lived cells that are constantly replaced by cells from the bone marrow. The lifespan of the cells is a critical determinant for the number of cells in the blood. As our preparation of bone marrow neutrophils seems to consist of terminally differentiated cells, we wanted to compare the lifespan of blood and bone marrow PMN. Neutrophils were kept under standard cell culture conditions for up to 48 h. After 24 h, almost all blood neutrophils were dead, and 25% of the bone marrow PMN survived. The time course of the number of viable cells revealed an exponential decay, which was significantly faster for blood PMN (Fig. 6A) . The half-life of bone marrow PMN in culture, calculated from the exponential fit of the time course, was twice as long as the half-life of blood PMN (PϽ0.05). Blood and bone marrow neutrophils appeared to enter apoptosis. They showed nuclear condensation like apoptotic human neutrophils [17] and loss of mitochondrial membrane potential (R. Boxio et al., unpublished data).
Taken together, the blood neutrophils and those of bone marrow were able to respond with the same intensity and the same affinity for the fMLF for at least three cellular functions. Thus, mouse bone marrow neutrophils exert the same antibacterial functions as blood neutrophils but have a longer lifespan.
DISCUSSION
Neutrophil differentiation is associated with changes in the buoyant density of the cells. Using identical density gradient centrifugation with leukocytes from the bone marrow and whole blood, we have obtained mouse neutrophil preparations that are similar with respect to morphology and function. The density of the bone marrow PMN was clearly above 1.09 g/l (69% Percoll), which is higher than the reported value for human bone marrow PMN (1.086 g/l) [7] . An alternative isolation method for mouse blood neutrophils using negative selection with antisurface antigen antibodies coupled to magnetic beads was recently described [18] . The technique is potentially less stimulating for the isolated cells. It could be extended to bone marrow preparations by adding antibodies against markers of immature precursor cells.
Previous studies have shown that bone marrow of humans and mice contains large numbers of myeloid cells with banded or segmented nuclei [4, 8] . Furthermore, surface markers for mature neutrophils have been found on mouse bone marrow cells [19, 20] . Based on the shape of the nuclei, our preparation of neutrophils from mouse bone marrow is indistinguishable from peripheral blood neutrophils. Our goal was to compare the functional qualities of mouse bone marrow neutrophils to blood neutrophils.
The chemotactic peptide fMLF is a major activator of human neutrophils, and recent studies have shown that mouse neutrophils also respond to this agonist with production of reactive oxygen species by the NADPH oxidase [21] . For a more detailed characterization, we have determined the EC 50 for fMLF, the kinetics, and the extent of the response. We found only a minor difference between blood and bone marrow PMN, whereas Berkow and Dodson [4] reported reduced ROI production in human bone marrow PMN.
Another action of fMLF is the stimulation of exocytosis. Neutrophils contain four distinct types of granules and secretory vesicles, which are released differentially [22, 23] . In general, the exocytosis of primary granules requires the strongest stimulation. This may reflect the need for stringent control of these granules, which contain the most aggressive substances. We demonstrate here that mouse neutrophils, like human neutrophils, release primary granules after stimulation with fMLF. Again, only minor differences between bone marrow and blood neutrophils appear. However, the EC 50 for primary granule release by fMLF from mouse blood neutrophils is 0.71 M compared with 0.01 M in human neutrophils [24] .
Like human neutrophils, stimulation of primary granule release by fMLF requires cytochalasin B. To our knowledge, this is the first demonstration of primary granule exocytosis from mouse neutrophils.
A similar picture is found for secondary granules. Their release from adherent mouse neutrophils has been shown before [6] . As in human PMN, PMA and Ca 2ϩ ionophore are stronger stimuli for secondary granules than for primary granules [25, 26] .
For primary granule release and NADPH-oxidase activation, peripheral blood neutrophils responded to fMLF with higher affinity than bone marrow cells. This may reflect the final steps of differentiation that enhance the responsiveness of the blood neutrophil for the activation of highly bactericidal mechanisms. Secondary granule release may be required before the direct contact with bacteria, thus earlier in the life of a neutrophil. This might explain why secondary granule release appeared to be more sensitive to fMLF in bone marrow cells. There might be a hierarchy in the installation of the bactericidal functions during the cellular maturation of the neutrophil.
Human bone marrow contains an important reserve pool of neutrophils [2] . The most likely role of the functional neutrophils in the bone marrow reserve pool is to replace peripheral neutrophils or supplement at times of increased demand during infection. The size of the reserve pool and the peripheral pool depends on the rate of synthesis, the lifespan of the cells, and the rates of migration into the bloodstream and into tissue. Releasing bone marrow cells with a longer lifespan into the blood is an effective way of increasing the number of circulating neutrophils. In the natural environment of the bone marrow, the difference in the half-life of the two cell populations may be larger than the twofold difference, which we observed under culture conditions. It has recently been suggested that aging mouse PMN may return to the bone marrow and be eliminated there [27] . This raised the possibility that our bone marrow preparation contained a large number of rapidly dying cells. However, we find that the half-life of these cells in culture is twice as long as that of blood neutrophils. The reported half-life of human blood PMN in culture is approximately 24 h [28] , thus substantially longer than in mice. This difference may contribute to the fact that the portion of neutrophils in the mouse white blood cell count is much lower than in human blood (5-25%, depending on the mouse strain, ref. [10] , vs. 60% of human blood leukocytes), and the total white blood cell count is similar. The literature suggests that neutrophils die by apoptosis, and their lifespan is regulated by the balance between pro-and antiapoptotic proteins under the influence of extracellular signals [3] . Our data are consistent with the idea that neutrophils receive antiapoptotic signals in the bone marrow, which are less present or absent in the bloodstream. Granulocyte-colony stimulating factor (G-CSF) and granulocyte macrophage (GM)-CSF may be among those signals, although GM-CSF had a much smaller effect on mouse neutrophils than G-CSF [29] . A mouse of 25 g body weight has ϳ50 ϫ 10 6 mature neutrophils in its bone marrow [8] and 2.3 ϫ 10 6 neutrophils in the blood (volume, ϳ1.9 ml). With a half-life of 6 h, ϳ10 ϫ 10 6 cells need to be replaced every day. Thus, the bone marrow reserve corresponds to 5 days of neutrophil production under normal conditions and less when more neu-trophils are needed to combat an infection. The reserve pool could also serve as a buffer for irregularities in the PMN development in the bone marrow, which takes 10 -14 days in humans [7] .
In summary, our findings suggest that mouse bone marrow contains a reserve pool of functionally mature neutrophils that might be readily mobilized when needed during bacterial infections. This pool contains 20 times more neutrophils than the blood. For numerous experiments with mouse neutrophils, the bone marrow may be an attractive and valuable alternative to peripheral blood. Nevertheless, certain studies will require several samples of blood neutrophils from the same animal during the course of the experiment, for example, the analysis of the neutrophil response during infection, drug treatment, or studies on nutrition.
